Medline Industries, a private company, secured a $77.6 million contract from the Department of Veterans Affairs for medical-surgical supplies. This contract highlights ongoing government demand for healthcare provisions, indirectly benefiting publicly traded medical supply distributors and healthcare service providers.
TICKER INTELLIGENCE
$AMN
Company & Legislative Profile
$AMN is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 11 active Congressional signals mentioning $AMN, including 8 bills and 3 federal contracts. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.
$AMN is currently facing 11 active congressional signals and 3 federal contracts tracked by HillSignal. With 6 bullish, 3 neutral, and 2 bearish signals, the average legislative impact score is 3.6/10. Key sectors affected include Healthcare, Technology and Real Estate. Recent major catalysts include MEDLINE INDUSTRIES, LP: $77.6M Department of Veterans Affairs Contract and Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act of 2025. Below is the complete tracker of government activity affecting $AMN’s market performance.
11
Total Signals
3.6/10
Avg Impact
6
Bullish Signals
2
Bearish Signals
Related Sectors
Recent Congressional Signals for $AMN
HR8272, introduced April 14, 2026, proposes classifying locum tenens and advanced care practitioners as independent contractors under the FLSA and NLRA. The bill is at the earliest legislative stage, referred to committee with zero appropriations. Passage probability is low. The primary beneficiaries — healthcare staffing firms like AMN Healthcare — see no near-term revenue impact. The bill has not moved markets.
HR7787 is an early-stage bill authorizing a mental health provider loan forgiveness program. It has been referred to committee with no companion bill, zero appropriations, and minimal legislative momentum. Market impact is negligible at this stage. Real market data shows AMN Healthcare at $20.65, up 12.6% over 30 days, and Centene at $53.22, up 62.55% over 30 days, driven by other factors unrelated to this procedural bill.
S.3033 mandates VA-rural hospital partnerships, creating revenue tailwinds for rural hospital operators ($HCA, $UHS) and healthcare staffing ($AMN) through mandatory co-location, leasing, and telehealth agreements. The bill is out of committee with bipartisan sponsorship but lacks funding authorization — actual impact requires future appropriations. Recent market data shows $AMN up 12.2% in 30 days, while $HCA and $UHS have declined sharply on separate sector pressures.
NORTH EAST SOUTH WEST HEALTHCARE SOLUTIONS, LLC: $16.5M Department of Homeland Security Contract
NEUTRALThis $16.5 million contract for medical staffing services to NORTH EAST SOUTH WEST HEALTHCARE SOLUTIONS, LLC, a private entity, suggests a stable demand for healthcare personnel within federal agencies. Publicly traded healthcare staffing companies like AMN Healthcare Services ($AMN) and Robert Half International ($RHI) may see a slight positive sentiment due to sustained government spending in this sector, though direct revenue impact is negligible.
NATIONWIDE HEALTHCARE SOLUTIONS, LLC: $16.9M Department of Health and Human Services Contract
NEUTRALThis $16.9M contract to NATIONWIDE HEALTHCARE SOLUTIONS, LLC for clinical support services is a moderate win for the private entity, but it highlights ongoing demand in the healthcare staffing and services sector, potentially benefiting publicly traded competitors.
The Fast Track Healthcare Apprenticeships Act (S.3364) mandates a 45-day registration timeline and digital forms for healthcare apprenticeships, reducing labor shortages in the sector. The bill is in early stage (referred to committee), but its bipartisan companion and moderate momentum signal potential passage. AMN Healthcare and Robert Half are positioned to benefit from increased workforce supply and digital implementation demand.
S.3607 expands Medicare Part B to cover genetic counseling as a new provider category effective Jan 1, 2027, directly increasing the addressable patient population for genetic testing. This is a structural positive for Labcorp ($LH) and Quest Diagnostics ($DGX) through higher test volume, and for AMN Healthcare ($AMN) through increased demand for scarce genetic counselors. The bill is at early legislative stage (referred to Finance Committee) with companion bill HR6280 in the House.
HR 6894 is an early-stage, low-probability bill that expands Medicare cardiac and pulmonary rehab supervision to PAs, NPs, and CNSs. It authorizes zero funding and remains in committee. Marginal upside for healthcare staffing firm AMN (allied health demand) is possible but contingent on passage. Labcorp (LH) sees no structural impact. Current market prices: AMN $20.62, LH $262.99.
SAFE Act
BULLISHThe SAFE Act expands Medicare to cover fall risk assessments and prevention services provided by physical and occupational therapists, effective January 2026. This creates a new reimbursable service line for outpatient therapy clinics like $USPH and increases staffing demand for agencies like $AMN. The bill is in early committee stage with bipartisan support (51 cosponsors) and a Senate companion, but no funding is authorized.
HR3415 mandates federal hospital nurse-to-patient ratios, imposing significant new labor costs on hospital operators ($HCA, $UHS, $THC, $CYH) while creating a structural tailwind for healthcare staffing firms ($AMN, $RHI). The bill has 40 cosponsors and a Senate companion, signaling meaningful advancement probability despite early legislative stage. Real market data confirms the trend: hospital stocks have declined 2-8% in 30 days, staffing firms have risen 5-14%.
Understanding These Signals
Get Full Access to $AMN Signals
Daily AI-analyzed alerts for Congressional activity affecting your portfolio.
Get Started →